Skip to content
SHM Abstracts | Society of Hospital Medicine Logo
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
Search2020-05-20T12:01:36-05:00
Search
Search by Abstract Number, Title, Keyword, or Authors
Category
Sub-Category

(Optional)

Distinguished Abstract
Meeting
Search Results for Leukemia Cutis
Abstract Number: 431
LEUKEMIA CUTIS: A RARE PRESENTATION IN CHRONIC MYELOID LEUKEMIA MASQUERADING AS CELLULITIS
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Case Presentation: A 48-year-old female with tyrosine kinase inhibitor-resistant CML on hydroxyurea therapy admitted with 3 weeks of fever, skin redness, and swelling. Her physical examination was remarkable for the temperature of 100.1 F, localized skin erythema, and tenderness around left antecubital fossa. Her labs revealed WBC of 80,000/ mm3 with 7% blast cells which [...]
  • This Week

  • This Month

  • All Time

  • This Week

  • A CASE OF AMANTADINE INDUCED LIVEDO RETICULARIS IN A PATIENT WITH MULTIPLE SCLEROSIS
  • NALTREXONE – INDUCED KRATOM WITHDRAWAL: A CALL FOR AWARENESS
  • Cannabis Withdrawal Induced Hypertensive Urgency
  • LOSARTAN-INDUCED ELECTROLYTE DEPLETION
  • RECOGNIZING S1Q3T3 FOR WHAT IT IS: A NONSPECIFIC PATTERN OF RIGHT HEART STRAIN
  • This Month

  • FEEDBACK THAT WORKS: IMPROVED BILLING THROUGH AUTOMATED PEER COMPARISON
  • A CASE OF AMANTADINE INDUCED LIVEDO RETICULARIS IN A PATIENT WITH MULTIPLE SCLEROSIS
  • NALTREXONE – INDUCED KRATOM WITHDRAWAL: A CALL FOR AWARENESS
  • Cannabis Withdrawal Induced Hypertensive Urgency
  • LOSARTAN-INDUCED ELECTROLYTE DEPLETION
  • All Time

  • FEEDBACK THAT WORKS: IMPROVED BILLING THROUGH AUTOMATED PEER COMPARISON
  • ADDERALL INDUCED ISCHEMIC COLITIS
  • A CASE OF SKIN NECROSIS CAUSED BY INTRAVENOUS XYLAZINE ABUSE
  • RECOGNIZING S1Q3T3 FOR WHAT IT IS: A NONSPECIFIC PATTERN OF RIGHT HEART STRAIN
  • Bc Powder Causing Intracerebral Bleed: Pitfalls of Overlooking Dosage of Seemingly Innocuous Otc Formulations
© Society of Hospital Medicine | All Rights Reserved | Privacy Policy
Page load link
Go to Top